Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Insulinoma × pasireotide × Clear all

Sponsor

Conditions

Pituitary Neoplasms 7 Acromegaly 4 Prostatic Neoplasms 3 Carcinoid Tumor 3 Pituitary ACTH Hypersecretion 2 Pancreatic Neoplasms 2 Neuroendocrine Tumors 2 Neoplasms 2 Growth Disorders 2 Gigantism 2 Carcinoma, Hepatocellular 2 Uveal Melanoma 1 Thyroid Neoplasms 1 Serotonin Syndrome 1 Prolactinoma 1 Primary Inoperable Thymoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Neuroectodermal Tumors, Primitive 1 Neoplasm Metastasis 1 Nelson Syndrome 1 Myelodysplastic Syndromes 1 Meningioma 1 Melanoma 1 Lymphoma 1 Liver Neoplasms 1 Leukemia, Myeloid, Acute 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Hematologic Neoplasms 1 Gastro-enteropancreatic neuroendocrine tumor 1 Dumping Syndrome 1

Interventions

Temozolomide 2 Everolimus 2 Capecitabine 2 Bevacizumab 2 regorafenib 1 pazopanib 1 motesanib diphosphate 1 batifiban 1 Sorafenib 1 Panobinostat 1 Oxaliplatin 1 Octreotide 1 Leucovorin 1 Fluorouracil 1 Fentanyl 1 Doxorubicin 1 Bortezomib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡